HAVN Life Sciences Inc. announced the departure of Mr. Tim Laidler as a director on the Board of the Company, effective September 29, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | -.--% | +20.00% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 632K | |
+33.68% | 49.46B | |
+1.56% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.69% | 26.61B | |
-21.04% | 18.64B | |
+7.39% | 13.16B | |
+28.64% | 12.55B | |
+23.85% | 12.1B |
- Stock Market
- Equities
- HAVN Stock
- News HAVN Life Sciences Inc.
- Havn Life Sciences Inc. Announces Departure of Mr. Tim Laidler as A Director